Abstract: Some embodiments of the invention are directed to an audio production system which is more portable, less expensive, faster to set up, and simpler and easier to use than conventional audio production tools. An audio production system implemented in accordance with some embodiments of the invention may therefore be more accessible to the typical user, and easier and more enjoyable to use, than conventional audio production tools.

Abstract: A container includes a housing defining a chamber. An edible colloid is carried within the chamber. An agitator is carried by the housing within the chamber and is adapted to agitate the edible colloid and provide a modified edible colloid. A dispenser is carried by the housing. The dispenser is adapted to dispense the modified edible colloid from the container.

Abstract: A system and method for sanitizing pneumatic conveying piping is provided. The system includes a motorized hose reel with a pig attached to the end of the hose. The pig is smaller in diameter than the inner diameter of the pipe through which it is conveyed. The decreased size of the pig keeps the conveying speed of the pig through the pipes down, while at the same time providing sufficient force to pull the supply hose attached to the pig through the pipes with the pig. The pig of some embodiments of the inventive concept is shaped as a hollow cone or frustoconical shape. Such a shape reduces weight of the pig and also allows the hose to be inserted through the body of the pig with a spray nozzle at the end. The hollow cone shape deflects relatively easily to allow the pig to go around corners or other obstructions. Also, such a pig design automatically centers the nozzle within the pipe during spraying.

Abstract: A system and method for sanitizing pneumatic conveying piping is provided. The system includes a motorized hose reel with a pig attached to the end of the hose. The pig is smaller in diameter than the inner diameter of the pipe through which it is conveyed. The decreased size of the pig keeps the conveying speed of the pig through the pipes down, while at the same time providing sufficient force to pull the supply hose attached to the pig through the pipes with the pig. The pig of some embodiments of the inventive concept is shaped as a hollow cone or frustoconical shape. Such a shape reduces weight of the pig and also allows the hose to be inserted through the body of the pig with a spray nozzle at the end. The hollow cone shape deflects relatively easily to allow the pig to go around corners or other obstructions. Also, such a pig design automatically centers the nozzle within the pipe during spraying.

Abstract: The present teachings provide compounds of Formula (I) and pharmaceutically acceptable salts, hydrates, and esters thereof, wherein Ar, R1, R2, R3, p, and X are defined herein. The present teachings also provide processes for producing said compounds and their pharmaceutically acceptable salts, hydrates and esters, and methods of treating a pathological condition or disorder, or alleviating a symptom thereof, using said compounds including their pharmaceutically acceptable salts, hydrates and esters. The compounds can be useful in modulating ion channel activity including treating a variety of conditions associated with the abnormal modulation of one or more voltage-gated calcium channels.

Abstract: The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.

Abstract: A universal serial bus connector assembly for sealing a plug against the intrusion of foreign material is provided. The connector assembly includes a plug receptacle housing and a plug receptacle supporting structure attached to the plug receptacle housing. A bezel is fitted over the plug receptacle supporting structure. A sealing elastomeric membrane is positioned between the plug receptacle supporting structure and the bezel. A slit is formed in the elastomeric membrane through which the plug is inserted into the plug receptacle housing.

Abstract: The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.

Abstract: A universal serial bus connector assembly for sealing a plug against the intrusion of foreign material is provided. The connector assembly includes a plug receptacle housing and a plug receptacle supporting structure attached to the plug receptacle housing. A bezel is fitted over the plug receptacle supporting structure. A sealing elastomeric membrane is positioned between the plug receptacle supporting structure and the bezel. A slit is formed in the elastomeric membrane through which the plug is inserted into the plug receptacle housing.

Abstract: The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.

Abstract: The present invention provides a MKV interceptor including multiple kill vehicles with autonomous management capability and kinematic reach to prosecute a large threat extent. Each KV can self-manage its own KV deployment and target engagement for a determined target volume assigned by a designated master KV. At least one KV is master capable of managing the post-separation of all of the KVs without requiring updates to the mission plan post-separation. The autonomous capability and increased kinematic reach provides for a more efficient use of boosters and more effective engagement of the threat.

Abstract: An optical fiber comprises a flame retardant tight-buffer coating. The tight-buffer coating has a limiting oxygen index of at least 20% and preferably has a durable tensile strength. Flame retardant, inner primary, outer primary, ink, ink base and single coatings and coating compositions as well as flame-retardant matrix materials are also provided.

Abstract: A network device has a first interface to allow communication with at least one network-capable camera and a second interface to allow communication with a network. A processor allows the device to receive video data from the network-capable camera receive commands for the cameras from the network and communicate them from the network. The network device may also have a video encoder to allow network-incapable cameras to communicate across the network. A method of managing a video surveillance data network receives data from a network-capable camera and registers the camera with a network management device. An identification number for the camera is provided and video data from the camera is transmitted across a network. Requests for communication with the camera are screened to only allow authorized users to access data from the camera.

Abstract: A carton is provided having multiple panels wherein at least a portion of the outer surface of at least one panel is printed with a soft feel material. This portion may be embossed, or may include the brand name and/or product logo.

Abstract: The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.

Abstract: The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.

Abstract: An optical fiber comprises a flame retardant tight-buffer coating. The tight-buffer coating has a limiting oxygen index of at least 20% and preferably has a durable tensile strength. Flame retardant, inner primary, outer primary, ink, ink base and single coatings and coating compositions as well as flame-retardant matrix materials are also provided.

Abstract: The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.

Abstract: The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient. This invention also relates to pharmaceutical compositions comprising these prodrugs. The prodrugs and pharmaceutical compositions of this invention are particularly well suited for decreasing the pill burden and increasing patient compliance. This invention also relates to methods of treating mammals with these prodrugs and pharmaceutical compositions.

Abstract: A method for drying the applicating finger of a contact lens wearer with sterile, lint-free, absorbent paper. The applicating finger is used to remove the contact lens from an aqueous solution. The lens is then transferred from the applicating finger, and the applicating finger is dried by contact with the sterile, lint-free, absorbent paper. Thereafter, the lens is returned to the dry applicating finger for insertion of the contact lens onto the eye.